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Background
Colorectal cancer (CRC) is third common cancer in
world. Both incidence and mortality of CRC in China
are increasing. Pooled individual data indicated that the
recurrent rate of colorectal adenoma (CRA) underwent
the polypectomy is high.
Methods
Papers in major gastroenterology journals published
were retrieved from MEDLINE. The data from my
group and other medical centers were also analyzed.
Results
Folic acid (FA) and butyrate suppress the cell prolifera-
tion in CRC cell lines and in mouse. The tumor inci-
dence in DMH group and DMH + butyrate group were
90% and 30%, respectively. And the subgroup of provid-
ing FA without precancerous lesions was more effective
than that with precancerous lesions.
The data from RCT, Cohort and case-control study
showed that many studies report that aspirin decrease the
incidence and mortality of CRC in average-risk persons,
aspirin and Celecoxib prevent the initial and recurrence of
advanced CRA. However, NSAID are ulcerogenic to the
stomach and duodenum and lead to a threefold to 10fold
increase in ulcer complications, hospitalisation, and death
from ulcer disease. Followed along with the increasing the
dose of cox2 inhibitors, although prevention effect
increased, while the serious cardiovascular events was
increased.
Many studies indicated that a dose-response inverse
association between dietary folate intake and risk of
colon cancer. However, the result from clinical trial
published in JAMA 2007 showed that FA at 1mg/d does
not reduce CRA recurrent risk, and was associated with
higher risks of having 3 or more adenomas and of non
CRC. In fact, the FA prevention effect is associated with
FA concentration at baseline. For patients who’s FA
concentration lower than 7.5ng/mL, FA decrease the
recurrence rate of CRA, but not patient who’s FA high
than 7.5 ng/ml. A report published in Am J Clin Nutr
indicated that folate intake and risk of CRC and CRA:
modification by time.
The association between fiber and colorectal neoplasia
has been intensively investigated. However, in some stu-
dies this topic remains controversial. Many studies
showed that calcium and vitamin D reduce risk of CRC.
We also found that calcium prevent the recurrence of
sporadic CRA.
Conclusions
The primary prevention for CRC contains the primary
and secondary prevention for CRA. Primary prevention
also is to reduce the incidence of CRA.
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